Member Info for andsoforth

Offer is actually worth 207.5p!!!!!

ADVT offer made this AM. Equates to about 210p. Weak offer in my opion.

Mr Ooi is a qualified medical doctor, an experienced entrepreneur and investor. He is the founder and Managing Director of the Serkona Group of private limited companies based in Australia with interests in multiple medical centres, commercial properties, and other unlisted assets. (I believe he may have been a metals trader in Hong Kong at one point).
https://www.investegate.co.uk/goldplat-plc--gdp-/rns/director-appointment/202110131218099763O/

The PUSU deadline has been pushed back, and we have now seen Canaccord dump around 4 million ADVT shares on behalf of a client, and the SAA price drop by c12% since the announcement. Bad omens!

Employees will be fine, and I am happy as long as a decent deal is struck that preserves my interest here.

...extended to 1700 on Friday 20 May. Looking for 200p minimum.

£300k to be paid out on new kit.
£2m cash on hand.
Operating profit up 96% on previous quarter.
Market cap £13.7m.
Turnaround finally here?

Q1 update:
Net operating income up 4%.
FUMA down 5%.
Decent performance in trying times.
Annual results due 28 July.

Agreed Me12345. This is a slight miss on estimates, so expect to see a slip today, but it may ne underpinned by the dividend.

Trading "broadly in line" (ie lower than hoped!)
In force policies down 8.7% over the year.
"The disciplined approach we have taken during Q1 and the operational progress we have made mean we can reiterate our combined operating ratio target of 93% to 95% in 2022."

Slight slippage here, possibly impacted by new regulations. May see improvements due to Motability customers and new software systems. Seems like a long term hold?

...due this Thursday 5 May.

The improved ADVT offer originally equated to above £2, but the decline in the ADVT share price has pushed it into the 190s. Very tangled here now.

https://www.londonstockexchange.com/news-article/SAA/issue-of-profit-forecasts/15430857

This is really putting the pressure on ADVT.

...and results are pretty decent, if phrased in a very complimentary way.
Operating profit up 12%.
EPS 10.5p.
Net cash £34m.
ADVT need to do better. Ms Murria may have shot her bolt here.

As you say, must be getting closer; but I am increasingly thinking this will see a simple rejection. If so, could be buying opportunities in SAA and ADVT.

...to close of play on Tuesday 10 May. Offer still not recommended, or made formal. Notes decline in ADVT share price means there is a substantial undervaluing of SAA (191p) in the current offer. This is not going to be easy!!!

Revs £9.78b beating mkt estimates £8.85. EPS small beat. Confirms guidance. On track to demerge and list its consumer healthcare business, Haleon, in July. Nice one!

T_o_D you are wise.

Totally agree T_o_D. JUP management have reportedly deployed £80m of company funds to deter a takeover (and to save their own jobs). Poor management in every context. BUT CLIG have not dissimilar results, and seems to be holding up better.

Rumour was some US outfit was interested, but no details given. 8.78% is not sustainable, but c5% is. The management needs a refresh here.